Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Non-Current Deferred Tax Liability (2016 - 2025)

Avanos Medical's Non-Current Deferred Tax Liability history spans 11 years, with the latest figure at $23.9 million for Q3 2024.

  • For Q3 2024, Non-Current Deferred Tax Liability fell 16.72% year-over-year to $23.9 million; the TTM value through Sep 2024 reached $23.9 million, down 16.72%, while the annual FY2023 figure was $70.7 million, 0.56% down from the prior year.
  • Non-Current Deferred Tax Liability for Q3 2024 was $23.9 million at Avanos Medical, up from $23.4 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $71.1 million in Q4 2022 and bottomed at $5.6 million in Q1 2021.
  • The 5-year median for Non-Current Deferred Tax Liability is $23.6 million (2024), against an average of $26.1 million.
  • The largest annual shift saw Non-Current Deferred Tax Liability tumbled 59.42% in 2021 before it soared 560.71% in 2022.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $5.7 million in 2020, then soared by 108.77% to $11.9 million in 2021, then soared by 497.48% to $71.1 million in 2022, then decreased by 0.56% to $70.7 million in 2023, then tumbled by 66.2% to $23.9 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Non-Current Deferred Tax Liability are $23.9 million (Q3 2024), $23.4 million (Q2 2024), and $23.6 million (Q1 2024).